ACTINEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actinex, and when can generic versions of Actinex launch?
Actinex is a drug marketed by Univ Az Cancer Ctr and is included in one NDA.
The generic ingredient in ACTINEX is masoprocol. There is one drug master file entry for this compound. Additional details are available on the masoprocol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACTINEX?
- What are the global sales for ACTINEX?
- What is Average Wholesale Price for ACTINEX?
Summary for ACTINEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 3,907 |
| DailyMed Link: | ACTINEX at DailyMed |
US Patents and Regulatory Information for ACTINEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univ Az Cancer Ctr | ACTINEX | masoprocol | CREAM;TOPICAL | 019940-001 | Sep 4, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACTINEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Univ Az Cancer Ctr | ACTINEX | masoprocol | CREAM;TOPICAL | 019940-001 | Sep 4, 1992 | 4,695,590 | ⤷ Start Trial |
| Univ Az Cancer Ctr | ACTINEX | masoprocol | CREAM;TOPICAL | 019940-001 | Sep 4, 1992 | 5,008,294 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACTINEX
See the table below for patents covering ACTINEX around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 8172487 | ⤷ Start Trial | |
| Australia | 1736088 | ⤷ Start Trial | |
| South Africa | 8803957 | ⤷ Start Trial | |
| Japan | S6479112 | TREATMENT OF TUMOR BY CATECHOL BUTANE COMPOSITION | ⤷ Start Trial |
| Canada | 1334170 | METHODE DE TRAITEMENT DE TUMEURS AVEC DES COMPOSITIONS A BASE DE BUTANES CATECHIQUES (METHODS OF TREATING TUMORS WITH COMPOSITIONS OF CATECHOLIC BUTANES) | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 8706829 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for ACTINEX
More… ↓
